Acme Progen Biotech (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 30-12-2024
- Paid Up Capital ₹ 1.00 M
as on 30-12-2024
- Company Age 17 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.90 M
as on 30-12-2024
- Revenue -19.54%
(FY 2020)
- Profit -7.73%
(FY 2020)
- Ebitda 141.23%
(FY 2020)
- Net Worth 9.01%
(FY 2020)
- Total Assets 9.73%
(FY 2020)
About Acme Progen Biotech (India)
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹1.90 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Appuchigounder Rathanam, Venkatesan Ganesan, and Mani Chitra serve as directors at the Company.
- CIN/LLPIN
U33111TZ2007PTC013847
- Company No.
013847
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jul 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Salem, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Acme Progen Biotech (India) Private Limited offer?
Acme Progen Biotech (India) Private Limited offers a wide range of products and services, including Material Testing Labs & Services, Laboratory Testing Services, Ayurvedic,Herbal Products & Medicine, Herbal Capsules, Medical Test Services, DNA Testing Service, Product Development Research, Genomics Research, Pharma & Bioanalytical Services, Pharmaceutical Services.
Who are the key members and board of directors at Acme Progen Biotech (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Appuchigounder Rathanam  | Director | 04-Apr-2018 | Current |
| Venkatesan Ganesan | Director | 30-Nov-2021 | Current |
| Mani Chitra | Director | 10-Jul-2007 | Current |
Financial Performance of Acme Progen Biotech (India).
Acme Progen Biotech (India) Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 19.54% decrease. The company also saw a slight decrease in profitability, with a 7.73% decrease in profit. The company's net worth moved up by a moderate rise of 9.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Acme Progen Biotech (India)?
In 2017, Acme Progen Biotech (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Srvis Education Resources Management LlpActive 5 years 1 monthAppuchigounder Rathanam is a mutual person
- Acme Corporate Management Services Private LimitedActive 18 years 7 months
Appuchigounder Rathanam is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 27 Jun 2018 | ₹1.00 M | Satisfied |
The Lakshmi Vilas Bank Ltd Creation Date: 05 Dec 2007 | ₹0.90 M | Satisfied |
How Many Employees Work at Acme Progen Biotech (India)?
Unlock and access historical data on people associated with Acme Progen Biotech (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Acme Progen Biotech (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acme Progen Biotech (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
